We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 15
Most popular |Most recent


A Win for Hemp in Court, and What it (Might) Mean for North Carolina

USA - September 17 2019 The hemp and cannabidiol ("CBD") industries today face substantial uncertainty, and they lack clear Federal rules, regulations, and guidance within...

Allen N. Trask, III.

Federal Trade Commission Joins in Warning Companies About Unsupported CBD Health Claims

USA - September 12 2019 Much of the regulatory "attention" regarding cannabidiol ("CBD") has been, understandably, focused on the U.S. Food and Drug Administration ("FDA")...

Allen N. Trask, III.

DEA Recognizes Legality of Hemp

USA - August 27 2019 On August 26, 2019, the U.S. Drug Enforcement Agency (or "DEA") issued a public notice that formally - and, finally! - expresses the agency's...

NC Legislative Update: Hemp Legislation Passes House; Headed Back to Senate

USA - August 23 2019 On August 21, the North Carolina House of Representatives voted, by a narrow margin, to advance Senate Bill 315 - North Carolina Farm Act of 2019...

Whitney Campbell Christensen, Allen N. Trask, III.

Where There’s Smoke, There’s Fire: The Raging Legislative Battle Over Smokable Hemp

USA - July 23 2019 Hemp and its derivatives - including hemp-derived cannabidiol ("CBD") - were previously classified as Schedule I controlled substances under the...

Allen N. Trask, III.